Case Control Study
Copyright ©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 557-570
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.557
Table 2 Main indicators of patients with cirrhosis with severe and non-severe dysbiosis

Severe dysbiosis (n = 24)
Non-severe dysbiosis (n = 24)
P value
Age, yr51.5 (42.0-59.0)50.0 (35.0-57.5)0.392
Body mass index, kg/m224.6 (22.8-27.7)24.2 (22.7-27.7)0.837
Male/female12/1211/130.500
Etiology of cirrhosis: Alcohol990.617
Autoimmune270.068
HBV720.068
HCV530.350
Cryptogenic130.304
Child–Turcotte–Pugh score9 (8-10)7 (6-9)0.047
Death1330.001
Death within the first year of follow-up520.092
Death during the following years of follow-up810.002
Esophageal varices (present/absent)20/418/60.477
Hepatic encephalopathy (overt/minimal/absent)11/9/46/11/70.288
Number connection test, seconds87 (65-118)79 (59-92)0.248
Ascites (present/absent)16/811/130.122
Spontaneous bacterial peritonitis (present/absent)0/240/241.000
Red blood cells, 1012 cell/L3.8 (3.4-4.0)3.9 (3.6-4.5)0.370
White blood cells, 109 cell/L3.8 (2.7-5.3)3.8 (3.1-5.2)0.628
Platelets, 109 cell/L87 (55-120)76 (60-108)0.860
Serum total protein, g/L70 (61-76)73 (64-78)0.599
Serum albumin, g/L31 (28-37)38 (34-41)0.009
Serum total bilirubin, μmol/L47 (31-62)31 (24-63)0.375
Prothrombin index (Quick test), %58 (48-67)64 (54-71)0.239
Creatinine, mg/dL0.69 (0.53-0.87)0.73 (0.66-0.90)0.187
Serum sodium, mmol/L141 (139-144)141 (138-143)0.795
Serum potassium, mmol/L4.3 (4.0-4.7)4.3 (4.1-4.7)0.844
Serum glucose, mmol/L5.1 (4.7-5.6)5.3 (4.7-6.0)0.260
Alanine aminotransferase, U/L36 (25-72)37 (23-60)0.804
Aspartate aminotransferase, U/L54 (41-98)40 (26-67)0.219
Gamma glutamyl transferase, U/L77 (40-148)76 (36-131)0.621
Alkaline phosphatase, U/L221 (188-340)222 (166-298)0.542
Cholinesterase, kU/L2.7 (1.9-3.7)4.0 (3.6-4.5)0.031
C-reactive protein, mg/L10.1 (2.1-16.1)2.1 (0.3-8.9)0.032
Splenic length, cm15.4 (14.0-17.6)16.1 (13.3-19.2)0.841